|
[1]
|
Lonardo, A., Byrne, C.D., Caldwell, S.H., et al. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease: Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 1388-1389. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Doycheva, I., Issa, D., Watt, K.D., et al. (2018) Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. Journal of Clinical Gastroenterology, 52, 339-346. [Google Scholar] [CrossRef]
|
|
[3]
|
Zhu, J.Z., Zhou, Q.Y., Wang, Y.M., et al. (2015) Prevalence of Fatty Liver Disease and the Economy in China: A Systematic Review. World Journal of Gastroenterology, 21, 5695-5706. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Younossi, Z.M., Golabi, P., Paik, J.M., et al. (2023) The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology, 77, 1335-1347. [Google Scholar] [CrossRef]
|
|
[5]
|
Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism: Clinical and Experimental, 65, 1038-1048. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zechner, R., Madeo, F. and Kratky, D. (2017) Cytosolic Lipolysis and Lipophagy: Two Sides of the Same Coin. Nature Reviews Molecular Cell Biology, 18, 671-684. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Shen, F., Zheng, R.D., Mi, Y.Q., et al. (2014) Controlled Attenuation Parameter for Non-Invasive Assessment of Hepatic Steatosis in Chinese Patients. World Journal of Gastroenterology, 20, 4702-4711. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Korbelius, M., Kuentzel, K.B., Bradić, I., et al. (2023) Recent Insights into Lysosomal Acid Lipase Deficiency. Trends in Molecular Medicine, 29, 425-438. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Viaud, M., Ivanov, S., Vujic, N., et al. (2018) Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production. Circulation Research, 122, 1369-1384. [Google Scholar] [CrossRef]
|
|
[10]
|
Ouimet, M., Franklin, V., Mak, E., et al. (2011) Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid Lipase. Cell Metabolism, 13, 655-667. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bowden, K.L., Dubland, J.A., Chan, T., et al. (2018) LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 1191-1201. [Google Scholar] [CrossRef]
|
|
[12]
|
European Association for the Study of the Liver (2015) EASL-ALEH Clinical Practice Guidelines: Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis. Journal of Hepatology, 63, 237-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Baratta, F., Pastori, D., Ferro, D., et al. (2019) Reduced Lysosomal Acid Lipase Activity: A New Marker of Liver Disease Severity across the Clinical Continuum of Non-Alcoholic Fatty Liver Disease? World Journal of Gastroenterology, 25, 4172-4180. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mashima, R. and Takada, S. (2022) Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study. International Journal of Molecular Sciences, 23, Article 15549. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Vargas-Alarcón, G., Posadas-Romero, C., Villarreal-Molina, T., et al. (2013) Single Nucleotide Polymorphisms within LIPA (Lysosomal Acid Lipase A) Gene Are Associated with Susceptibility to Premature Coronary Artery Disease. A Replication in the Genetic of Atherosclerotic Disease (GEA) Mexican Study. PLOS ONE, 8, e74703. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Pasta, A., Borro, P., Cremonini, A.L., et al. (2021) Effect of a Common Missense Variant in LIPA Gene on Fatty Liver Disease and Lipid Phenotype: New Perspectives from a Single-Center Observational Study. Pharmacology Research & Perspectives, 9, e00820. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association and Fatty Liver Expert Committee, Chinese Medical Doctor Association (2018) [Guidelines of Prevention and Treatment for Nonalcoholic Fatty Liver Disease: A 2018 Update]. Chinese Journal of Hepatology, 26, 195-203.
|
|
[18]
|
Evans, T.D., Zhang, X., Clark, R.E., et al. (2019) Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated with Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 2480-2491. [Google Scholar] [CrossRef]
|
|
[19]
|
Ahmadian, M., Duncan, R.E., Jaworski, K., et al. (2007) Triacylglycerol Metabolism in Adipose Tissue. Future Lipidology, 2, 229-237. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Boadu, E., Bilbey, N.J. and Francis, G.A. (2008) Cellular Cholesterol Substrate Pools for Adenosine-Triphosphate Cassette Transporter A1-Dependent High-Density Lipoprotein Formation. Current Opinion in Lipidology, 19, 270-276. [Google Scholar] [CrossRef]
|
|
[21]
|
Oram, J.F. and Heinecke, J.W. (2005) ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter that Protects against Cardiovascular Disease. Physiological Reviews, 85, 1343-1372. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Maxfield, F.R. and Tabas, I. (2005) Role of Cholesterol and Lipid Organization in Disease. Nature, 438, 612-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Koga, H., Kaushik, S. and Cuervo, A.M. (2010) Altered Lipid Content Inhibits Autophagic Vesicular Fusion. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 24, 3052-3065. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Emanuel, R., Sergin, I., Bhattacharya, S., et al. (2014) Induction of Lysosomal Biogenesis in Atherosclerotic Macrophages Can Rescue Lipid-Induced Lysosomal Dysfunction and Downstream Sequelae. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1942-1952. [Google Scholar] [CrossRef]
|
|
[25]
|
Morris, G.E., Braund, P.S., Moore, J.S., et al. (2017) Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1050-1057. [Google Scholar] [CrossRef]
|
|
[26]
|
Guo, X., Yin, X., Liu, Z., et al. (2022) Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences, 23, Article 15489. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Miura, K., Kodama, Y., Inokuchi, S., et al. (2010) Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice. Gastroenterology, 139, 323-334. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Chen, Z., Tian, R., She, Z., et al. (2020) Role of Oxidative Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Free Radical Biology & Medicine, 152, 116-141. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Guénard, F., Houde, A., Bouchard, L., et al. (2012) Association of LIPA Gene Polymorphisms with Obesity-Related Metabolic Complications among Severely Obese Patients. Obesity, 20, 2075-2082. [Google Scholar] [CrossRef] [PubMed]
|